Biomerica, Inc.
NASDAQBMRA heads into the final days of April with a notable split: short sellers have been retreating steadily as the company just unlocked a meaningful new commercial door. The dominant story this week is the Medicare development. On April 16, Biomerica announced that a Medicare Administrative Contractor confirmed individual claim review eligibility for its inFoods® IBS diagnostic…
Snapshot as of 11 May 2026
BMRA heads into the final days of April with a notable split: short sellers have been retreating steadily as the company just unlocked a meaningful new commercial door. The dominant story this week is the Medicare…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BMRA — free to start on ORTEX.
Sign up for free →Open BMRA on ORTEX